Recent Company News

• 11:11 AM ET Aug 24, 2026
  

  Follow-up: StreetAccount Summary - Private company transactions for the week ended 22-Aug

• 09:35 AM ET Aug 24, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 22-Aug

• 04:36 PM ET Aug 20, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:34 AM ET Aug 20, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 02:01 PM ET Aug 17, 2026
  

  FDA grants orphan drug designation to Dynavax's rF1V Vaccine with CpG 1018 for the prevention of plague (Yersinia pestis) (€76.66, 0.00)

• 09:52 AM ET Aug 17, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 15-Aug

• 09:44 AM ET Aug 10, 2026
  

  Sanofi's medications for Pompe disease facing shortages - STAT News ($43.50, +0.04)

• 09:39 AM ET Aug 10, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 08-Aug

• 07:07 AM ET Aug 04, 2026
  

  Nurix announces $10M milestone payment associated with initiation of Phase 1 clinical trial of STAT6 degrader ($23.22, 0.00)

• 01:01 AM ET Aug 04, 2026
  

  European Commission (EC) approves Sanofi's MenQuadfi for use in infants from age six weeks against invasive meningococcal disease (€74.50, 0.00)